Saved in:
| Main Authors: | Gicquel, Malo, Zhao, Ruoyi, Wuestefeld, Anika, Spotorno, Nicola, Strandberg, Olof, Åström, Kalle, Xiao, Yu, Wisse, Laura EM, van Westen, Danielle, Ossenkoppele, Rik, Mattsson-Carlgren, Niklas, Berron, David, Hansson, Oskar, Flood, Gabrielle, Vogel, Jacob |
|---|---|
| Format: | Preprint |
| Published: |
2025
|
| Subjects: | |
| Online Access: | https://arxiv.org/abs/2507.13782 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Longitudinal tau‐PET accumulation and downstream effects in amyloid‐beta negative cognitively unimpaired individuals
by: Anika Wuestefeld, et al.
Published: (2025)
by: Anika Wuestefeld, et al.
Published: (2025)
Predicting cognitive decline in amyloid‐negative individuals with amnestic mild cognitive impairment
by: Amanda Annettesdotter, et al.
Published: (2025)
by: Amanda Annettesdotter, et al.
Published: (2025)
Predicting cognitive decline in amyloid‐negative individuals with amnestic mild cognitive impairment
by: Amanda Annettesdotter, et al.
Published: (2025)
by: Amanda Annettesdotter, et al.
Published: (2025)
The MRI signature of alpha‐synuclein pathology in preclinical stages and in a memory clinic population
by: Laura E.M. Wisse, et al.
Published: (2024)
by: Laura E.M. Wisse, et al.
Published: (2024)
Associations between tau accumulation and cognitive decline across the AD continuum differ by sex
by: Ellen Hanna Singleton, et al.
Published: (2024)
by: Ellen Hanna Singleton, et al.
Published: (2024)
Associations between tau accumulation and cognitive decline across the AD continuum differ by sex
by: Ellen Hanna Singleton, et al.
Published: (2024)
by: Ellen Hanna Singleton, et al.
Published: (2024)
Lewy body pathology exacerbates brain hypometabolism and cognitive decline in Alzheimer’s disease
by: Lyduine E. Collij, et al.
Published: (2024)
by: Lyduine E. Collij, et al.
Published: (2024)
Complementary utility of plasma biomarkers and Aβ‐PET for diagnosis, risk‐stratification, and treatment monitoring in Alzheimer's disease
by: Lyduine E. Collij, et al.
Published: (2025)
by: Lyduine E. Collij, et al.
Published: (2025)
Impact of regional MAPT, APOE, and Aβ on tau propagation in Alzheimer’s disease: Insights from a connectome‐based simulation model
by: Yu Xiao, et al.
Published: (2024)
by: Yu Xiao, et al.
Published: (2024)
Hemispheric Asymmetry of Amyloid Deposition Influences Asymmetric Tau Pathology in Alzheimer's Disease
by: Toomas Erik Anijärv, et al.
Published: (2025)
by: Toomas Erik Anijärv, et al.
Published: (2025)
CSF and plasma proteomic insights into the pathophysiology of cerebral small vessel disease and cerebrovascular event risk prediction
by: Ines Hristovska, et al.
Published: (2025)
by: Ines Hristovska, et al.
Published: (2025)
Data‐driven progression patterns of Aβ, tau, α‐synuclein and vascular pathology in a clinical population
by: Sophie E. Mastenbroek, et al.
Published: (2024)
by: Sophie E. Mastenbroek, et al.
Published: (2024)
Proteomic profiles in Lewy body pathology and the presence of AD co‐pathology
by: Irene Cumplido‐Mayoral, et al.
Published: (2025)
by: Irene Cumplido‐Mayoral, et al.
Published: (2025)
Unlocking Tau PET Accessibility: a Machine Learning‐Based Prediction of Tau Pathology from Plasma, MRI and Clinical Variables
by: Linda Karlsson, et al.
Published: (2024)
by: Linda Karlsson, et al.
Published: (2024)
Proteomics analysis characterizing new markers related to Aβ plaques and tau tangles pathologies
by: Alexa Pichet Binette, et al.
Published: (2024)
by: Alexa Pichet Binette, et al.
Published: (2024)
APOE ε4 ‐related proteomic profiles in plasma and CSF
by: Lina Lu, et al.
Published: (2025)
by: Lina Lu, et al.
Published: (2025)
Regional Amyloid Load Predicts Tau and Atrophy Dynamics
by: Pavan Chaggar, et al.
Published: (2024)
by: Pavan Chaggar, et al.
Published: (2024)
A self‐administered digital cognitive test together with a blood test accurately detect clinical Alzheimer's disease in primary care
by: Pontus Tideman, et al.
Published: (2025)
by: Pontus Tideman, et al.
Published: (2025)
Individual variation in proteomic cascades along the Alzheimer’s disease spectrum
by: Jacob W. Vogel, et al.
Published: (2024)
by: Jacob W. Vogel, et al.
Published: (2024)
Disease timeline modelling of amyloid and tau PET reveals dynamic timescales of amyloid and tau accumulation in Alzheimer's disease
by: Alexandra L Young, et al.
Published: (2025)
by: Alexandra L Young, et al.
Published: (2025)
Benchmarking the AI‐based diagnostic potential of plasma proteomics for neurodegenerative disease in 17,710 people
by: Lijun An, et al.
Published: (2025)
by: Lijun An, et al.
Published: (2025)
Biological staging of Alzheimer’s disease with the novel plasma eMTBR‐tau243 and % p ‐tau217
by: Gemma Salvadó, et al.
Published: (2025)
by: Gemma Salvadó, et al.
Published: (2025)
Role of tau versus TDP‐43 pathology on medial temporal lobe atrophy in aging and Alzheimer's disease
by: Laura E. M. Wisse, et al.
Published: (2025)
by: Laura E. M. Wisse, et al.
Published: (2025)
Can longitudinal measures of plasma biomarkers track disease progression in early Alzheimer´s Disease?
by: Divya Bali, et al.
Published: (2025)
by: Divya Bali, et al.
Published: (2025)
How Implementation of Bibliometric Practice Affects the Role of Academic Libraries
by: Åström, Fredrik, et al.
Published: (2013)
by: Åström, Fredrik, et al.
Published: (2013)
Discriminating AD Biomarker Groups Based on a Digital Speech Biomarker for Cognition (SB‐C)
by: Alexandra König, et al.
Published: (2025)
by: Alexandra König, et al.
Published: (2025)
Comparison of plasma biomarkers measured on a fully automated instrument versus CSF biomarkers for detecting Alzheimer’s disease pathology
by: Noëlle Warmenhoven, et al.
Published: (2025)
by: Noëlle Warmenhoven, et al.
Published: (2025)
SONNET: Enhancing Time Delay Estimation by Leveraging Simulated Audio
by: Tegler, Erik, et al.
Published: (2024)
by: Tegler, Erik, et al.
Published: (2024)
PixCuboid: Room Layout Estimation from Multi-view Featuremetric Alignment
by: Hanning, Gustav, et al.
Published: (2025)
by: Hanning, Gustav, et al.
Published: (2025)
Sparse Multiview Open-Vocabulary 3D Detection
by: Moliner, Olivier, et al.
Published: (2025)
by: Moliner, Olivier, et al.
Published: (2025)
Evaluation of the prospective use of blood biomarkers for Alzheimer’s disease in primary and secondary care
by: Sebastian Palmqvist, et al.
Published: (2024)
by: Sebastian Palmqvist, et al.
Published: (2024)
Coordinated multi‐cellular responses to Alzheimer's disease pathology reveal sex‐specific resilience signatures
by: Gabriele Vilkaite, et al.
Published: (2025)
by: Gabriele Vilkaite, et al.
Published: (2025)
Improved Anomaly Detection through Conditional Latent Space VAE Ensembles
by: Åström, Oskar, et al.
Published: (2024)
by: Åström, Oskar, et al.
Published: (2024)
Deposition patterns of proteinopathies in medial temporal lobe subregions: implications for neuroimaging
by: Laura E.M. Wisse, et al.
Published: (2025)
by: Laura E.M. Wisse, et al.
Published: (2025)
Clinical usefulness of plasma p ‐tau217 and eMTBR‐tau243 combination for diagnosis and patient stratification
by: Niklas Mattsson‐Carlgren, et al.
Published: (2025)
by: Niklas Mattsson‐Carlgren, et al.
Published: (2025)
Clinical staging in Swedish primary care using the Amsterdam Instrumental Activities of Daily Living Questionnaire
by: Ayesha Fawad, et al.
Published: (2026)
by: Ayesha Fawad, et al.
Published: (2026)
Diffusion MRI in the cortex of the brain: Reducing partial volume effects from CSF and white matter in the mean diffusivity using high b‐values and spherical b‐tensor encoding
by: Cornelia Säll, et al.
Published: (2025)
by: Cornelia Säll, et al.
Published: (2025)
Single-Source Localization as an Eigenvalue Problem
by: Larsson, Martin, et al.
Published: (2025)
by: Larsson, Martin, et al.
Published: (2025)
Clinical performance of blood biomarkers across settings and countries
by: Sebastian Palmqvist, et al.
Published: (2025)
by: Sebastian Palmqvist, et al.
Published: (2025)
The association between tau pathology and later stages of memory processing is mediated by medial temporal lobe atrophy in typical Alzheimer's Disease
by: Anika Wuestefeld, et al.
Published: (2024)
by: Anika Wuestefeld, et al.
Published: (2024)
Similar Items
-
Longitudinal tau‐PET accumulation and downstream effects in amyloid‐beta negative cognitively unimpaired individuals
by: Anika Wuestefeld, et al.
Published: (2025) -
Predicting cognitive decline in amyloid‐negative individuals with amnestic mild cognitive impairment
by: Amanda Annettesdotter, et al.
Published: (2025) -
Predicting cognitive decline in amyloid‐negative individuals with amnestic mild cognitive impairment
by: Amanda Annettesdotter, et al.
Published: (2025) -
The MRI signature of alpha‐synuclein pathology in preclinical stages and in a memory clinic population
by: Laura E.M. Wisse, et al.
Published: (2024) -
Associations between tau accumulation and cognitive decline across the AD continuum differ by sex
by: Ellen Hanna Singleton, et al.
Published: (2024)